Hologic, Inc. is an American medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.[2]
History
Hologic completed its acquisition of Cytyc Corporation on October 22, 2007[4], in a cash-and-stock transaction valued at approximately $6.2 billion. Cytyc expanded Hologic’s presence in women’s health diagnostics and therapies, adding products such as the ThinPrep Pap test for cervical cancer screening, NovaSure endometrial ablation technology, and related diagnostic and imaging capabilities.[5]
In late November 2013, activist investor Carl Icahn disclosed a 12.5% stake in the company. Subsequently, the company adopted a poison pill to prevent a hostile takeover. In negotiations with the company's board of directors, two additional directors backed by Icahn were added to the board, each managing directors of Icahn holding companies.